课题基金 / 基金详情

项目摘要

项目成果

Ilya Shpitser的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Good adherence to anti-retroviral therapy (ART) is widely accepted as a key factor for sustained viral suppression of human immunodeficiency virus (HIV), and is often considered a prerequisite for maintenance on a prescribed drug regimen and optimal patient outcomes. However, the extent to which adherence to a given choice of therapy (relative to another therapy), contributes to virologic failure is complex and stll poorly understood, and is a pressing mediation question in HIV research. Understanding this issue is particularly important in resource poor settings where ART regimen options are limited and adherence to lifelong multi- drug daily dosing is challenging but necessary. In such settings, quantifying to what degree differential rates of virologic failure are due to difference in adherence rates between therapies would inform the extent to which failure rates could be improved by programs that increase adherence rates for certain ARTs, rather than improving ART regimens themselves. Such adherence interventions have been very successful in the treatment of tuberculosis and are considered important in the treatment of HIV. Unfortunately, traditional approaches to mediation analysis assume static settings with no unobserved confounding, and are thus not suited for analysis of complex longitudinal data typically encountered in observational studies of HIV. Our plan is to remedy this deficiency using recent developments in causal inference based on potential outcomes and graphical models, and modern semi-parametric theory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation missing data methods in HIV research
  • 批准号:
    9348941
  • 项目类别:
  • 资助金额:
    $73.25万
  • 财政年份:
    2017
  • 负责人:
    Ilya Shpitser
  • 依托单位:
Identification and Inference for Longitudinal Causal Mediation Analysis in HIV
  • 批准号:
    8603033
  • 项目类别:
  • 资助金额:
    $37.95万
  • 财政年份:
    2013
  • 负责人:
    Ilya Shpitser
  • 依托单位:
海外基金